TY - JOUR
T1 - Arterial cerebral infarcts in sickle cell trait and antithrombin III deficiency
AU - Comas, Pere
AU - D’Olhaberriague, Luis
AU - López, Merce
AU - Soler-Singla, Lluis
AU - Pascual, Jordi
AU - Matali, Arantxa
AU - Pou-Serradell, Adolf
PY - 1991/1/1
Y1 - 1991/1/1
N2 - Since September 1987, all patients under 46 years admitted to our Hospital with cerebral infarcts (Cl), the cause of which was unknown, have undergone complete hematological screening (partial thromboplastin time; prothrombin ratio; fibrinogen level; lupus anticoagulant activity; fibrinolytic capacity; proteins C and S; antilhrom- bin III; AT-III, and hemoglobin electrophoresis when indicated). In 2 out of 22 patients admitted in 1988, sickle cell trait and AT-III deficiency were the only abnormalities identified. We conclude that complete hematological screening should be carried out in every young patient with Cl when more common causes are not present. © 1991 S. Karger AG, Basel.
AB - Since September 1987, all patients under 46 years admitted to our Hospital with cerebral infarcts (Cl), the cause of which was unknown, have undergone complete hematological screening (partial thromboplastin time; prothrombin ratio; fibrinogen level; lupus anticoagulant activity; fibrinolytic capacity; proteins C and S; antilhrom- bin III; AT-III, and hemoglobin electrophoresis when indicated). In 2 out of 22 patients admitted in 1988, sickle cell trait and AT-III deficiency were the only abnormalities identified. We conclude that complete hematological screening should be carried out in every young patient with Cl when more common causes are not present. © 1991 S. Karger AG, Basel.
KW - Antithrombin III, deficiency of
KW - Ischemic stroke in young
KW - Sickle cell trait
UR - https://www.scopus.com/pages/publications/84939671607
U2 - 10.1159/000108836
DO - 10.1159/000108836
M3 - Article
SN - 1015-9770
VL - 1
SP - 168
EP - 170
JO - Cerebrovascular Diseases
JF - Cerebrovascular Diseases
IS - 3
ER -